The “FDA Decisions for Investigational Device Exemption (IDE) Clinical Investigations” draft guidance describes new approaches to early feasibility studies in an effort to foster early-stage development of medical devices.
The “Investigational Device Exemptions (IDE) for Early Feasibility Medical Device Clinical Studies, including First in Human (FIH) Studies” draft guidance outlines the FDA’s process for approving applications from companies wanting to conduct clinical trial involving medical devices.
Related Articles on the FDA:
John Stossel: The FDA is Killing Us
FDA Extends Comment Period on 510(k) Document
FDA Launches Website on Safe Disposal of Used Needles and Other “Sharps”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
